Mylan And Biocon Launch Fulphila In Canada

Biosimilar Pegfilgrastim Rival To Neulasta Joins Apotex’ Lapelga Version

 
• By David Wallace
  
Canada_Victory_Sign
Mylan and Biocon’s Fulphila is the second biosimilar pegfilgrastim in Canada • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Products

More from Generics Bulletin